| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/01/1996 | CN1121707A Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 05/01/1996 | CN1121421A Tianlingkangfu pill for recovery |
| 05/01/1996 | CN1031713C Process for preparing 9-purinyl phosphonic acid derivatives |
| 05/01/1996 | CN1031705C Process for preparing 24-homo-vitamin-D-derivatives |
| 04/30/1996 | US5512675 Methods for preparing porphyrin-like compounds |
| 04/30/1996 | US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids |
| 04/30/1996 | US5512559 Method of treating cancer tumors with imine porphyrin compounds |
| 04/30/1996 | US5512556 For the prevention and treatment of mammary tumors |
| 04/30/1996 | US5512550 Method for inhibiting angiogenesis with modified platelet factor-4 and cleaved platelet factor-4 |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | CA1338302C Therapeutic octapeptide somatostatin analogs |
| 04/29/1996 | CA2154543A1 Human 26s proteasome subunit components |
| 04/25/1996 | WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 04/25/1996 | WO1996011954A1 Tc or re radiolabelled somatostatin analogs |
| 04/25/1996 | WO1996011953A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | WO1996011938A1 Oligonucleotide and carcinostatic agent containing the same as active ingredient |
| 04/25/1996 | WO1996011935A1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same |
| 04/25/1996 | WO1996011933A1 Fused pyrrolocarbazoles |
| 04/25/1996 | WO1996011712A2 Cell-specific gene delivery vehicles |
| 04/25/1996 | WO1996011681A1 Preventive and remedy for diarrhea |
| 04/25/1996 | WO1996011677A1 Methods for treating resistant tumors |
| 04/25/1996 | WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 04/25/1996 | CA2472085A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | CA2202661A1 Methods for treating resistant tumors |
| 04/25/1996 | CA2202478A1 Cell-specific gene delivery vehicles |
| 04/25/1996 | CA2202389A1 Agent for preventing and treating diarrhea |
| 04/25/1996 | CA2202169A1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same |
| 04/24/1996 | EP0708099A1 Tricyclic amide compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/24/1996 | EP0707849A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/24/1996 | EP0707585A1 Bicyclic tetrahydro pyrazolopyridines |
| 04/24/1996 | EP0707566A1 Novel structural analogues of vitamin d |
| 04/24/1996 | EP0707480A1 Antineoplastic compositions and methods of use |
| 04/24/1996 | EP0707479A1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| 04/24/1996 | EP0489070B1 Novel inhibitors of thrombin |
| 04/24/1996 | EP0380542B1 Method for treating malignancy and autoimmune disorders in humans |
| 04/24/1996 | CN1121347A Method and apparatus for extracting taxol from source materials |
| 04/24/1996 | CN1121346A 10,11-methanodibenzosuberane derivaties used as chemosensitizing agents |
| 04/24/1996 | CN1121311A Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 04/24/1996 | CN1121075A Alkaloids from mappia foetida, the use thereof and formulations containing them |
| 04/24/1996 | CN1031643C Novel glycoside compounds and production thereof |
| 04/23/1996 | US5510469 2-acyloxy-4-morpholinyl anthracyclines |
| 04/23/1996 | US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt |
| 04/23/1996 | US5510239 One of the intersugar linkages between nuclotide units of the oligonuclotide is phosphorothioate linkage |
| 04/23/1996 | US5510105 Lysing unwanted non-malignant cells(lymphocytes)involved in transplant rejection in a mammal |
| 04/23/1996 | CA1338262C Antitumor antibiotic kedarcidin |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | WO1996011208A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/18/1996 | WO1996011200A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | WO1996011184A1 Colchicine derivatives and the therapeutical use thereof |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996011007A1 Parenteral pharmaceutical compositions containing gf120918a |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | CA2201773A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | CA2201628A1 Parenteral pharmaceutical compositions containing gf120918a |
| 04/17/1996 | EP0707071A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 04/17/1996 | EP0706994A1 Melatonergic agents |
| 04/17/1996 | EP0706799A2 Immunoconjugates II |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706581A1 Dna profiles as an indicator of cellular redox potential and cancer risk |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
| 04/17/1996 | EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 04/17/1996 | EP0706533A1 Synthetic peptides of human papillomavirus |
| 04/17/1996 | EP0706521A1 Novel imides |
| 04/17/1996 | EP0706516A1 Ansamycin derivatives as antioncogene and anticancer agents |
| 04/17/1996 | EP0683665A4 Magnetically responsive composition for carrying biologically active substances and methods of production and use. |
| 04/17/1996 | EP0651822B1 Diagnostic method |
| 04/17/1996 | EP0493468B1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/17/1996 | CN1120845A 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity |
| 04/17/1996 | CN1120840A Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 04/16/1996 | US5508403 Enhances effects of antitumor agents |
| 04/16/1996 | US5508387 Selectin binding glycopeptides |
| 04/16/1996 | US5508310 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 04/16/1996 | US5508305 2, 4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 04/16/1996 | US5508290 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508289 Bis-acridone chemotherapeutic derivatives |
| 04/16/1996 | US5508286 Rapamycin amidino carbamates |
| 04/16/1996 | US5508285 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508279 Increases urine flow while avoiding hypotensive effects |
| 04/16/1996 | US5508277 Administering to suppress tumor cell resistance to antineoplastic drugs |
| 04/16/1996 | CA1338245C Compound dc-107 and process for its preparation |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010639A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 04/11/1996 | WO1996010574A1 Method for preparing concentrated biologically active silicon compounds |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | WO1996010404A1 Antineoplastic cocoa extracts, methods for making, using |
| 04/11/1996 | WO1996005866A3 Live vaccine for the treatment of tumour diseases |
| 04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |